Jan 11, 2023
Calciscon-led Consortium is Awarded a €2M Eurostars Project to Further the Availability of T50
CALCISCON, AMSTERDAM UNIVERSITY MEDICAL CENTERS and ADMESY have signed a collaborative agreement for the development of a laboratory benchtop analyzer for the measurement of the T50 test. T50 is a unique test for the measurement of calcification propensity in a blood sample. The primary use of T50 is to revolutionize the treatment of patients suffering from chronic kidney disease, particularly dialysis patients, with the potential to significantly reduce their cardiovascular burden. The collaboration partners combine excellence in calcification in vitro diagnostics (Calciscon), in-depth know-how on optical detection systems (Admesy) and world-renown expertise in clinical chemistry and nephrology research (Amsterdam UMC). The CALPROTECT consortium is supported by €2M Eurostars funding.
© 2023 by CALCISCON | Privacy Policy